The global healthcare landscape is undergoing a monumental shift toward precision medicine, with cancer diagnostics sitting at the vanguard of this transformation. As oncology moves away from a one size fits all approach, the identification and utilization of biological indicators have become paramount. The Cancer Biomarkers Market is experiencing a period of robust expansion, driven by the...